Efalizumab in the treatment of psoriasis: mode of action, clinical indications, efficacy, and safety.
about
Extracellular matrix molecules: potential targets in pharmacotherapy.Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents.Glutathione peroxidase activity in the blood cells of psoriatic patients correlates with their responsiveness to Efalizumab.Pig embryonic pancreatic tissue as a source for transplantation in diabetes: transient treatment with anti-LFA1, anti-CD48, and FTY720 enables long-term graft maintenance in mice with only mild ongoing immunosuppression.Angiogenesis drives psoriasis pathogenesis.Inhibition of LFA-1/ICAM-1-mediated cell adhesion by stilbene derivatives from Rheum undulatum.Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis.Old and New Biological Therapies for Psoriasis.The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis.
P2860
Q33694487-F392A578-F337-4F55-A8E1-483A1F62FD87Q34110804-43781B32-B333-4699-B08E-148EEE93E6D5Q34112840-E6A446D9-9B52-4571-A419-571BCEA976CAQ34626982-BD099A97-4A2F-4AEE-8EEB-778E3BAA0B45Q37236287-415C8479-6B82-4954-83A5-33D05B8CD824Q37534974-4275B3D1-5EF2-48D5-B324-115C59CBDFDBQ39247443-616199EB-1500-43CA-A74D-B270E0DBEBDEQ41899890-C9EBDD88-FB2D-4369-A83B-9882B673B92EQ47859049-32625339-F8AB-45D9-9AF9-D281D68DB8A8Q55386458-F34D3AB3-4ED7-4C20-90ED-923CE60E2C15
P2860
Efalizumab in the treatment of psoriasis: mode of action, clinical indications, efficacy, and safety.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efalizumab in the treatment of ...... cations, efficacy, and safety.
@en
Efalizumab in the treatment of ...... cations, efficacy, and safety.
@nl
type
label
Efalizumab in the treatment of ...... cations, efficacy, and safety.
@en
Efalizumab in the treatment of ...... cations, efficacy, and safety.
@nl
prefLabel
Efalizumab in the treatment of ...... cations, efficacy, and safety.
@en
Efalizumab in the treatment of ...... cations, efficacy, and safety.
@nl
P1476
Efalizumab in the treatment of ...... cations, efficacy, and safety.
@en
P304
P356
10.1016/J.CLINDERMATOL.2007.10.027
P577
2008-09-01T00:00:00Z